(This is associative evidence and may reflect confounding by indication, surveillance patterns, and glycaemic differences.) For post-marketing pharmacovigilance, FAERS-based analyses of semaglutide identify multiple safety signals (e.g., gastrointestinal obstruction-related terms, dehydration/volume depletion in some GLP-1RA analyses), but vulvovaginal dryness/infection/discharge/pain are not prominent as labelled risks in the major semaglutide FAERS disproportionality paper retrieved here
V., Herremans, N., de Laet, C., & Goyens, P
Prepare your dose Prepare your dose based on the instructions enclosed in your medication shipment
A collaboration between the UK Health Security Agency (UKHSA) and sleep app Sleep Cycle is aimed to find out how signals recorded by the app, such as coughing at night, correspond to UK hospital admission data and surveillance indicators